Classification of Tumor Marker and their association to type of malignancies

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532131/table/tbl1/?report=objectonly



References

1. Sell S. Serological cancer markers. Totowa, New Jersey: The Humana Press. 1992 [Google Scholar]

2. Bence-Jones H. Pathology Papers on Chemical Lecture III. Lancet. 1847;2:269–272. [Google Scholar]

3. Sell S, Cancer Markers. In. In: Moossa AR, Schempff SC, Robson MC, editors. Comprehensive Text book on Oncology. Williams and Wilkins; Baltimore: 1991. pp. 225–238. [Google Scholar]

4. Abelev G I, Perova S D, Khramkova N I. Production of embryonal alpha – globulins by transplantable mouse hepatomas. Transplantation. 1963;1:174–180. [PubMed] [Google Scholar]

5. Gold P, Freeman SO. Demonstration of tumor specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med. 1965;121:439–462. [PMC free article] [PubMed] [Google Scholar]

6. Fishman WH, Sell S. Onco-developmental gene expression: A preview. In: Fishman WH, Sell S, editors. Onco-Developmental Gene Expression. Academic Press Inc; New York: 1976. [Google Scholar]

7. Knudson Jr A G. Hereditary cancer, oncogenes, and antioncogene. Cancer Res. 1985;45:1437–1481. [PubMed] [Google Scholar]

8. Sidransky D, Tokino T, Hamilton SR. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumor. Science. 1992;256:102–105. [PubMed] [Google Scholar]

9. Petty E M, Killeen AA. BRCA – mutation testing, controversies and challenges. Clin Chem. 1997;43:6–8. [PubMed] [Google Scholar]

10. Chan D W, Sell S. Markers Tumor. In: Burtis Ashwood A C, editor. Tietz Text Book of Clinical chemistry 3rd ed. Harcourt Brace & Company Asia PTE Ltd; Singapore: 1999. pp. 722–749. [Google Scholar]

11. Wu J T. Diagnosis and management of cancer using serological tumot markers. In: Henry J B, editor. Clinical Diagnosis and Management by Laboratory Methods. W B Saunders; New York: 1996. pp. 1064–1080. [Google Scholar]

12. Deb P, Deshpande G U, Rai R. Correlation of hormone receptor status, p53 mutation and c erb B-2 over expression with nuclear grading in breast cancer. MJAFI. 2000;56:4. [Google Scholar]

13. Chu T M. Prostate Specific Antigen. In: Sell S, editor. Serological Cancer Marker. The Humana Press; Totowa, New Jersey: 1992. pp. 99–115. [Google Scholar]

14. Hlkens J. Disease biochemistry and function of mucin in malignant. Cancer Rev. 1988:24–54. [Google Scholar]